An artificial intelligence device that can detect diabetic eye problems has been approved by The Food and Drug Administration (FDA) of the United States. It allows the doctors to diagnose the condition without the need for any data or images. An artificial intelligence algorithm is used by the device to analyze images of the eye, taken with a retinal camera Topcon NW400. The image is then uploaded to a cloud server on which IDx-DR software is installed. The IDx-DR software scans the image and subsequently responds to the condition of the patient's eye. The response could either be that the ‘patient's eye problem is more than mild’ and he should seek treatment from a specialist, or it is ‘negative for diabetic retinopathy’ and he can be rescreened in a year. the need for a clinician. This feature lets the regular health care providers diagnose diabetic eye problems. The device can help doctors in detecting ‘Diabetic Retinopathy’, the most common cause of vision loss among the more than 30 million Americans living with diabetes. The use of this device is not recommended for people with a history of laser treatment, surgery in the eye; those with persistent vision loss, blurred vision or certain retinal disorders. The use of the device is also not recommended for pregnant women as diabetic retinopathy progresses very rapidly and the device is not intended to assess rapidly progressive diabetic retinopathy.